AI English summary of an SEC filing — figures as filed
Abbott Laboratories ABTAbbott said it entered into a Five Year Credit Agreement on January 29, 2024 with JPMorgan Chase Bank, N.A., as administrative agent, allowing it to borrow up to $5 billion on an unsecured basis.
Key points
AI summaryAbbott said it entered into a Five Year Credit Agreement on January 29, 2024 with JPMorgan Chase Bank, N.A., as administrative agent, allowing it to borrow up to $5 billion on an unsecured basis.
The company said borrowings under the agreement will mature and be payable on the 5th anniversary of the effective date, and that there are no outstanding borrowings under the agreement as of the date of this report.
The company said borrowings under the agreement bear interest, at its option, at either a base rate or a SOFR rate, plus an applicable margin tied to its credit ratings, and that it will also pay customary fees to the lenders.
Abbott said that in connection with the new agreement, it terminated all commitments under its existing Five Year Credit Agreement effective on November 12, 2020, that there were no outstanding borrowings at the time of termination, and that absent termination, its borrowings would have matured on November 12, 2025.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Abbott Enters $5 billion Five-Year Unsecured Revolving Credit Agreement
Abbott said it entered into a Five Year Credit Agreement on January 29, 2024 with JPMorgan Chase Bank, N.A., as administrative agent, allowing it to borrow up to $5 billion on an unsecured basis.
Source · Based on the filing body and exhibits
Borrowing Maturity and Current Outstanding Balance
The company said borrowings under the agreement will mature and be payable on the 5th anniversary of the effective date, and that there are no outstanding borrowings under the agreement as of the date of this report.
Source · Based on the filing body and exhibits
Interest Terms on Borrowings
The company said borrowings under the agreement bear interest, at its option, at either a base rate or a SOFR rate, plus an applicable margin tied to its credit ratings, and that it will also pay customary fees to the lenders.
Source · Based on the filing body and exhibits
Termination of Existing $5 billion Credit Agreement
Abbott said that in connection with the new agreement, it terminated all commitments under its existing Five Year Credit Agreement effective on November 12, 2020, that there were no outstanding borrowings at the time of termination, and that absent termination, its borrowings would have matured on November 12, 2025.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…